TORONTO, Feb. 19 /PRNewswire-FirstCall/ -- MDS Inc. (TSX:MDS; NYSE: MDZ), a global life sciences company, provided an update today on the closing of the sale of its Canadian laboratory services business, MDS Diagnostic Services, to Borealis Infrastructure Management Inc. MDS and Borealis Infrastructure Management Inc. have agreed on a scheduled closing of the transaction on February 23, 2007. About MDS Inc. MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 8,800 highly skilled people in 28 countries. Find out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a day. DATASOURCE: MDS Inc. CONTACT: Investors: Kim Lee, Manager, Investor Relations, MDS Inc., (416) 675-6777 x32606, ; Media: Catherine Melville, Director, External Communications, MDS Inc., (416) 675-6777 x 32265,

Copyright